九鼎投資(600053.SH):一季度房地產簽約額同比增657.31%至778.29萬元
格隆匯4月14日丨九鼎投資(600053.SH)公佈2022年第一季度房地產業務經營情況簡報,房地產開發方面,第一季度,紫金城住宅(底商)簽約金額778.29萬元,同比增長657.31%,簽約面積627.25平方米,同比增長510.34%。此外,紫金城共計153個車位簽約,簽約金額1183.00萬元,同比分別增長7550.00%、增長4829.17%。
房屋出租方面,第一季度九鼎投資寫字樓出租面積10,067.37平方米,出租率57.27%,租金收入137.66萬元;其他無。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.